# Ultra-Long GnRH-a Pretreatment for FET Outcomes in Patients With Deep Infiltrating Endometriosis

> **NCT07696351** · PHASE4 · RECRUITING · sponsor: **Li-jun Ding** · enrollment: 120 (estimated)

## Conditions studied

- Deep Infiltrating Endometriosis (DIE)
- Infertility

## Interventions

- **DRUG:** Triptorelin (GnRH agonists)
- **OTHER:** Hormone Replacement Therapy (HRT)

## Key facts

- **NCT ID:** NCT07696351
- **Lead sponsor:** Li-jun Ding
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-08-01
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-07-31
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2026-07-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07696351

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07696351, "Ultra-Long GnRH-a Pretreatment for FET Outcomes in Patients With Deep Infiltrating Endometriosis". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07696351. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*